Studies have shown that active fund managers routinely underperform the S&P500 index*​

Tango Therapeutics, Inc. (NASDAQ: TNGX)

TNGX Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-14.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
31.30%

TNGX Stock Analysis

TNGX PE Ratio:

TNGX PEG Ratio: Not Available

TNGX Forward EPS Growth (12 month): 0.00%

TNGX PS Ratio: 43.8

TNGX PSG Ratio: Not Available

TNGX Forward Revenue Growth (12 month): 0.00%

TNGX Articles

No data was found